O-4 GLUT 選択的阻害薬 STF-3 の高リスク多発性骨髄腫に対する治療薬としての可能性 Therapeutic potential of a selective GLUT inhibitor STF-3 for high-risk multiple myeloma 松本太一 自見至郎 2 髙

Hiroshima University: Ethical Committee for Clinical Research of Hiroshima University, Nara Medical University: Medical Ethics Committee of Nara Medical University, Mie

3 Department of Respiratory Medicine, Cellular Transplantation Biology, Graduate School of Medicine, Kanazawa University, Japan. Reprints : Asao Sakai, Respiratory Medicine,

＊2 Kanazawa University, Institute of Science and Engineering, Faculty of Geosciences and civil Engineering, Associate Professor. ＊3 Kanazawa University, Graduate School of

の多くの場合に腺腫を認め組織学的にはエオヂ ン嗜好性細胞よりなることが多い．叉性機能減

人間社会学域 College of Human and Social Sciences 理工学域. 医薬保健学域 College of Medical,Pharmaceutical and

医薬保健学域 College of Medical,Pharmaceutical and Health Sciences 医学類

免疫チェックポイント阻害薬に分類される抗PD-L1抗 体であるアテゾリズマブとVEGF阻害薬のベバシズマ

Department of Orthopedic Surgery Okayama University Medical School Okayama Japan.. in